Cargando…
Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia
Mutations of the p53 tumour suppressor gene are infrequent at presentation of both acute myeloblastic leukaemia (AML) and acute lymphoblastic leukaemia (ALL), being found in between 5–10% of AML and 2–3% of ALL. Here we have studied the frequency of detection of p53 mutations at relapse of both AML...
Autores principales: | Zhu, Y-M, Foroni, L, McQuaker, I G, Papaioannou, M, Haynes, A, Russell, H H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362216/ https://www.ncbi.nlm.nih.gov/pubmed/10098750 http://dx.doi.org/10.1038/sj.bjc.6690183 |
Ejemplares similares
-
Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia
por: Ma, Xiaotu, et al.
Publicado: (2015) -
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia
por: Furness, Caroline L, et al.
Publicado: (2018) -
Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia
por: Collord, Grace, et al.
Publicado: (2018) -
Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA
por: Groves, F D, et al.
Publicado: (1999) -
Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia.
por: Kearney, P. J., et al.
Publicado: (1979)